Phase 2b Trial of the PDE10A Inhibitor MK-8189 in People With an Acute Episode of Schizophrenia. Mukai Y, Kost J, Snow-Adami L, Reed J, et al. J Clin Psychopharmacol 2026 Feb 23. doi: 10.1097/JCP.0000000000002152.

Read + Share

Amedeo Smart

Independent Medical Education

Mukai Y, Kost J, Snow-Adami L, Reed J, et al. Phase 2b Trial of the PDE10A Inhibitor MK-8189 in People With an Acute Episode of Schizophrenia. J Clin Psychopharmacol 2026 Feb 23. doi: 10.1097/JCP.0000000000002152.
PMID: 41724750